Clinical application value and prospect of peripheral blood circulating microRNA in hepatocellular carcinoma / 肿瘤研究与临床
Cancer Research and Clinic
; (6): 223-228, 2023.
Article
en Zh
| WPRIM
| ID: wpr-996215
Biblioteca responsable:
WPRO
ABSTRACT
Early diagnosis, effective treatment and monitoring of recurrence and metastasis of hepatocellular carcinoma have always been difficult problems for clinicians. MicroRNA (miRNA) plays an important role in hepatocellular carcinoma cells' proliferation, apoptosis, metabolism and other processes, and can be released into body fluids such as blood, urine and saliva. The peripheral blood miRNA in hepatocellular carcinoma can be used as biomarkers for the diagnosis, efficacy assessment, recurrence and metastasis monitoring and prognosis judgment, and may even become therapeutic targets for hepatocellular carcinoma. This article summarizes the research progress of circulating miRNA in peripheral blood as markers for diagnosis and treatment monitoring of hepatocellular carcinoma.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Cancer Research and Clinic
Año:
2023
Tipo del documento:
Article